M. Elze

1.4k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

M. Elze is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, M. Elze has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Molecular Biology. Recurrent topics in M. Elze's work include Diabetes Treatment and Management (5 papers), Statistical Methods in Clinical Trials (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). M. Elze is often cited by papers focused on Diabetes Treatment and Management (5 papers), Statistical Methods in Clinical Trials (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). M. Elze collaborates with scholars based in Germany, United States and Italy. M. Elze's co-authors include Shamik Parikh, Stefano Del Prato, Katja Rohwedder, Michael A. Nauck, S. Durán‐García, Juris J. Meier, Krzysztof Strojek, Kun‐Ho Yoon, Veronika Hrubá and Anna Maria Langkilde and has published in prestigious journals such as Diabetes Care, European Journal of Pharmaceutical Sciences and The Pediatric Infectious Disease Journal.

In The Last Decade

M. Elze

18 papers receiving 1.1k citations

Hit Papers

Dapagliflozin Versus Glipizide as Add-on Therapy in Patie... 2011 2026 2016 2021 2011 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin
    2011 427 citations Michael A. Nauck, Stefano Del Prato et al. Diabetes Care profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Elze Germany 9 756 572 364 190 125 18 1.1k
Seiko Otokozawa United States 20 585 0.8× 296 0.5× 552 1.5× 69 0.4× 43 0.3× 28 1.4k
M.P.C. Hectors Netherlands 14 349 0.5× 239 0.4× 479 1.3× 36 0.2× 75 0.6× 35 1.3k
Chie Aoki Japan 22 171 0.2× 260 0.5× 217 0.6× 69 0.4× 28 0.2× 46 1.0k
Chul Ho Lee South Korea 17 114 0.2× 320 0.6× 138 0.4× 40 0.2× 99 0.8× 53 910
Charles M. Bliss United States 8 95 0.1× 252 0.4× 319 0.9× 49 0.3× 101 0.8× 14 1.0k
Taiji Mizoguchi Japan 16 88 0.1× 928 1.6× 222 0.6× 29 0.2× 63 0.5× 26 1.5k
Christelle Vachoux France 10 138 0.2× 565 1.0× 98 0.3× 41 0.2× 68 0.5× 12 962
N Vidon France 17 117 0.2× 138 0.2× 224 0.6× 78 0.4× 74 0.6× 50 887
Annika Lundqvist Sweden 16 68 0.1× 528 0.9× 94 0.3× 29 0.2× 32 0.3× 33 927
Terrilyn A. Richardson United States 11 83 0.1× 308 0.5× 93 0.3× 157 0.8× 10 0.1× 12 1.1k

Countries citing papers authored by M. Elze

Since Specialization
Citations

This map shows the geographic impact of M. Elze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Elze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Elze more than expected).

Fields of papers citing papers by M. Elze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Elze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Elze. The network helps show where M. Elze may publish in the future.

Co-authorship network of co-authors of M. Elze

This figure shows the co-authorship network connecting the top 25 collaborators of M. Elze. A scholar is included among the top collaborators of M. Elze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Elze. M. Elze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Nauck, Michael A., Stefano Del Prato, Jasmin Meier, et al.. (2013). Vergleich von Dapagliflozin und Glipizid als Add-on-Therapie bei Typ-2-Diabetikern mit unzureichender Blutzuckerkontrolle unter Metformin. DMW - Deutsche Medizinische Wochenschrift. 138(S 01). S6–S16. 6 indexed citations
2.
Strojek, Krzysztof, Kun‐Ho Yoon, Veronika Hrubá, et al.. (2013). Effekt von Dapagliflozin bei Typ-2-Diabetikern mit unzureichender Blutzuckereinstellung unter Glimepirid. DMW - Deutsche Medizinische Wochenschrift. 138(S 01). S16–S27. 2 indexed citations
3.
Nauck, Michael A., Stefano Del Prato, Jasmin Meier, et al.. (2013). [Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin].. DMW - Deutsche Medizinische Wochenschrift. 138 Suppl 1(1). S6–15. 12 indexed citations
4.
Strojek, Krzysztof, Kun‐Ho Yoon, Veronika Hrubá, et al.. (2011). Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24‐week, double‐blind, placebo‐controlled trial. Diabetes Obesity and Metabolism. 13(10). 928–938. 344 indexed citations
5.
Nauck, Michael A., Stefano Del Prato, Juris J. Meier, et al.. (2011). Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin. Diabetes Care. 34(9). 2015–2022. 427 indexed citations breakdown →
6.
Henker, J, Martin W. Laaß, Б.М. Блохин, et al.. (2008). Probiotic Escherichia coli Nissle 1917 Versus Placebo for Treating Diarrhea of Greater Than 4 Days Duration in Infants and Toddlers. The Pediatric Infectious Disease Journal. 27(6). 494–499. 76 indexed citations
7.
Henker, J, Martin W. Laaß, Б.М. Блохин, et al.. (2007). The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers. European Journal of Pediatrics. 166(4). 311–318. 152 indexed citations
8.
Staab, Alexander, et al.. (2003). Pharmacokinetics and bioavailability of denaverine hydrochloride in healthy subjects following intravenous, oral and rectal single doses. European Journal of Pharmaceutical Sciences. 18(2). 121–128. 2 indexed citations
9.
Heinrich-Nols, Jutta, et al.. (1999). Bioequivalence study of two morphine extended release formulations after multiple dosing in healthy volunteers.. PubMed. 37(3). 153–8. 1 indexed citations
10.
Windeler, Jürgen, Hans J. Trampisch, M. Elze, et al.. (1996). Recommendations concerning Studies on Therapeutic Equivalence. Drug Information Journal. 30(1). 195–200. 10 indexed citations
11.
Blume, Henning, et al.. (1996). [The relative bioavailability of paracetamol in suppositories in comparison to tablets].. PubMed. 46(10). 975–80. 4 indexed citations
12.
Potthast, Henrike, et al.. (1995). [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state].. PubMed. 50(1). 56–60. 2 indexed citations
13.
Steinijans, V W, et al.. (1995). Metrics to Characterize Concentration-Time Profiles in Single- and Multiple-Dose Bioequivalence Studies. Drug Information Journal. 29(3). 981–987. 7 indexed citations
14.
Steinijans, V W, Dieter Hauschke, E Diletti, et al.. (1995). Reference tables for the intrasubject coefficient of variation in bioequivalence studies.. PubMed. 33(8). 427–30. 31 indexed citations
15.
Hauschke, Dieter, et al.. (1994). Presentation of the intrasubject coefficient of variation for sample size planning in bioequivalence studies.. PubMed. 32(7). 376–8. 14 indexed citations
16.
Blume, Henning, et al.. (1994). [Relative bioavailability of paracetamol in suppositories preparations in comparison to tablets].. PubMed. 44(12). 1333–8. 9 indexed citations
17.
Blume, Henning, et al.. (1994). Advantages of a steady-state crossover design in assessment of bioequivalence of highly variable drugs: propafenone. European Journal of Pharmaceutical Sciences. 2(5-6). 385–393. 7 indexed citations
18.
Spahn‐Langguth, H., Gabriele Hahn, E. Mutschler, et al.. (1994). P166 determination of the bioavailability of tranylcypromine with a stereospecific assay. European Journal of Pharmaceutical Sciences. 2(1-2). 160–160. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seiko Otokozawa Breakdown of academic impact, for papers by M.P.C. Hectors Breakdown of academic impact, for papers by Chie Aoki Breakdown of academic impact, for papers by Chul Ho Lee Breakdown of academic impact, for papers by Charles M. Bliss Breakdown of academic impact, for papers by Taiji Mizoguchi Breakdown of academic impact, for papers by Christelle Vachoux Breakdown of academic impact, for papers by N Vidon Breakdown of academic impact, for papers by Annika Lundqvist Breakdown of academic impact, for papers by Terrilyn A. Richardson
Rankless by CCL
2026